1. II Medical Department, "Coburg" Regional Hospital, University of Wuerzburg, Coburg, Germany.
2. Pulmonary Department-Oncology Unit, "G. Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
J Cancer. 2014 Mar 9;5(3):231-41. doi: 10.7150/jca.8834. eCollection 2014.
Currently there are several advanced guiding techniques for pathoanatomical diagnosis of incidental solitary pulmonary nodules (iSPN): Electromagnetic navigation (EMN) with or without endobronchial ultrasound (EBUS) with miniprobe, transthoracic ultrasound (TTUS) for needle approach to the pleural wall and adjacent lung and computed tomography (CT) -guidance for (seldom if ever used) endobronchial or (common) transthoracical approach. In several situations one technique is not enough for efficient diagnosis, therefore we investigated a new diagnostic technique of endobronchial guided biopsies by a Cone Beam Computertomography (CBCT) called DynaCT (SIEMENS AG Forchheim, Germany).
In our study 33 incidental solitary pulmonary nodules (iSPNs) (28 malignant, 5 benign; mean diameter 25 +/-12mm, shortest distance to pleura 25+/-18mm) were eligible according to in- and exclusion criteria. Realtime and onsite navigation were performed according to our standard protocol.22 All iSPN were controlled with a second technique when necessary and clinical feasible in case of unspecific or unexpected histological result. In all cases common guidelines of treatment of different iSPNs were followed in a routine manner.
Overall navigational yield (ny) was 91% and diagnostic yield (dy) 70%, dy for all accomplished malignant cases (n=28) was 82%. In the subgroup analysis of the invisible iSPN (n=12, 11 malignant, 1 benign; mean diameter 15+/-3mm) we found an overall dy of 75%. For the first time we describe a significant difference in specifity of biopsy results in regards to the position of the forceps in the 3-dimensional volume (3DV) of the iSPN in the whole sample group. Comparing the specifity of biopsies of a 3D-uncentered but inside the outer one third of an iSPN-3DV with the specifity of biopsies of centered forceps position (meaning the inner two third of an iSPN-3DV) reveals a significant (p=0,0375 McNemar) difference for the size group (>1cm) of 0,9 for centered biopsies vs. 0,3 for uncentered biopsies. Therefore only 3D-centered biopsies should be relied on especially in case of a benign result.
The diagnostic yield of DynaCT navigation guided transbronchial biopsies (TBB) only with forceps is at least up to twofold higher than conventional TBB for iSPNs <2cm. The diagnostic yield of DynaCT navigation guided forceps TBB in invisible SPNs is at least in the range of other navigation studies which were performed partly with multiple navigation tools and multiple instruments. For future diagnostic and therapeutic approaches it is so far the only onsite and realtime extrathoracic navigation approach (except for computed tomography (CT)-fluoroscopy) in the bronchoscopy suite which keeps the working channel open. The system purchase represents an important investment for hospitals but it is a multidisciplinary and multinavigational tool with possible access via bronchial airways, transthoracical or vascular approach at the same time and on the same table without the need for an expensive disposable instrument use.
目前,有几种先进的技术可用于偶然发现的孤立性肺结节(iSPN)的病理解剖学诊断:电磁导航(EMN)结合或不结合使用微型探头的支气管内超声(EBUS)、经胸超声(TTUS)用于接近胸膜壁和相邻肺的针道以及计算机断层扫描(CT)引导(很少使用)经支气管或(常见)经胸方法。在某些情况下,一种技术不足以进行有效的诊断,因此我们研究了一种新的支气管内引导活检技术,称为锥形束 CT(CBCT),称为 DynaCT(德国西门子公司 Forchheim)。
根据纳入和排除标准,我们的研究纳入了 33 个偶然发现的孤立性肺结节(iSPN)(28 个恶性,5 个良性;平均直径 25 +/-12mm,最短距离到胸膜 25+/-18mm)。根据我们的标准方案进行实时和现场导航。所有 iSPN 都在必要时通过第二种技术进行了控制,并且在出现非特异性或意外组织学结果时在临床可行的情况下进行。在所有情况下,都按照不同 iSPN 的常规治疗指南进行治疗。
总体导航成功率(ny)为 91%,诊断成功率(dy)为 70%,dy 用于所有已完成的恶性病例(n=28)为 82%。在不可见 iSPN 的亚组分析中(n=12,11 个恶性,1 个良性;平均直径 15+/-3mm),我们发现总体 dy 为 75%。我们首次描述了活检结果的特异性在整个样本组中,在 iSPN 的 3 维体积(3DV)中钳子位置的影响。比较 3D 未中心化但位于 iSPN-3DV 外三分之一的活检的特异性与中心化钳子位置(意味着 iSPN-3DV 的内三分之二)的活检特异性,揭示了大小组(>1cm)的显著差异(p=0.0375 McNemar),中心化活检的特异性为 0.9,而非中心化活检的特异性为 0.3。因此,特别是在良性结果的情况下,仅应依赖 3D 中心化活检。
DynaCT 导航引导经支气管活检(TBB)的诊断成功率至少比常规 TBB 高两倍,适用于 <2cm 的 iSPN。DynaCT 导航引导的钳子 TBB 在不可见 SPN 中的诊断成功率至少与其他导航研究相当,这些研究部分采用了多种导航工具和多种仪器。对于未来的诊断和治疗方法,它是目前支气管镜检查室中唯一的现场和实时的胸外导航方法(除了计算机断层扫描(CT)-透视外),它保持工作通道畅通。系统采购对医院来说是一项重要的投资,但它是一种多学科、多导航工具,可以通过支气管气道、经胸或血管途径同时进入,无需使用昂贵的一次性仪器。